Wockhardt Reports Strong Q2 Revenue Growth of 11% Driven by International Businesses
Pharmaceutical company Wockhardt recently announced its financial results for the second quarter and first half of fiscal year 2023, ending September 30th, 2023. The results show strong revenue growth of 11% in Q2 and first half of FY2023, driven by Wockhardt’s international businesses in the UK, emerging markets, and Ireland. Q2 FY2023 Revenue Up 11% […]